Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Assessment of lipid, hepatic, and thyroid parameters with serum perfluorooctanoate (PFOA) concentrations in fluorochemical production workers.

Olsen GW, Zobel LR.

Int Arch Occup Environ Health. 2007 Nov;81(2):231-46. Epub 2007 Jun 29.

PMID:
17605032
2.

Plasma cholecystokinin and hepatic enzymes, cholesterol and lipoproteins in ammonium perfluorooctanoate production workers.

Olsen GW, Burris JM, Burlew MM, Mandel JH.

Drug Chem Toxicol. 2000 Nov;23(4):603-20.

PMID:
11071397
3.
4.

Comparative responses of rats and mice exposed to linear/branched, linear, or branched ammonium perfluorooctanoate (APFO).

Loveless SE, Finlay C, Everds NE, Frame SR, Gillies PJ, O'Connor JC, Powley CR, Kennedy GL.

Toxicology. 2006 Mar 15;220(2-3):203-17. Epub 2006 Jan 31.

PMID:
16448737
5.

Characterization of hepatic responses of rat to administration of perfluorooctanoic and perfluorodecanoic acids at low levels.

Kawashima Y, Kobayashi H, Miura H, Kozuka H.

Toxicology. 1995 May 23;99(3):169-78.

PMID:
7610463
6.

The toxicology of perfluorooctanoate.

Kennedy GL Jr, Butenhoff JL, Olsen GW, O'Connor JC, Seacat AM, Perkins RG, Biegel LB, Murphy SR, Farrar DG.

Crit Rev Toxicol. 2004 Jul-Aug;34(4):351-84. Review.

PMID:
15328768
7.

Perfluorooctanoic acid (PFOA), an emerging drinking water contaminant: a critical review of recent literature.

Post GB, Cohn PD, Cooper KR.

Environ Res. 2012 Jul;116:93-117. doi: 10.1016/j.envres.2012.03.007. Epub 2012 May 4. Review.

PMID:
22560884
8.

Longitudinal assessment of lipid and hepatic clinical parameters in workers involved with the demolition of perfluoroalkyl manufacturing facilities.

Olsen GW, Ehresman DJ, Buehrer BD, Gibson BA, Butenhoff JL, Zobel LR.

J Occup Environ Med. 2012 Aug;54(8):974-83. doi: 10.1097/JOM.0b013e31825461d2.

PMID:
22842914
9.

A methodology for estimating human exposure to perfluorooctanoic acid (PFOA): a retrospective exposure assessment of a community (1951-2003).

Paustenbach DJ, Panko JM, Scott PK, Unice KM.

J Toxicol Environ Health A. 2007 Jan;70(1):28-57.

PMID:
17162497
10.

A cross-sectional analysis of type II diabetes in a community with exposure to perfluorooctanoic acid (PFOA).

MacNeil J, Steenland NK, Shankar A, Ducatman A.

Environ Res. 2009 Nov;109(8):997-1003. doi: 10.1016/j.envres.2009.08.002. Epub 2009 Sep 8.

PMID:
19740462
11.

Age effect on perfluorooctanoate (PFOA) plasma concentration in post-weaning rats following oral gavage with ammonium perfluorooctanoate (APFO).

Hinderliter PM, Han X, Kennedy GL, Butenhoff JL.

Toxicology. 2006 Aug 15;225(2-3):195-203. Epub 2006 Jun 9.

PMID:
16857306
12.

Characterization of risk for general population exposure to perfluorooctanoate.

Butenhoff JL, Gaylor DW, Moore JA, Olsen GW, Rodricks J, Mandel JH, Zobel LR.

Regul Toxicol Pharmacol. 2004 Jun;39(3):363-80.

PMID:
15135214
13.
14.

Toxicogenomic analysis of the hepatic effects of perfluorooctanoic acid on rare minnows (Gobiocypris rarus).

Wei Y, Liu Y, Wang J, Tao Y, Dai J.

Toxicol Appl Pharmacol. 2008 Feb 1;226(3):285-97. Epub 2007 Oct 4.

PMID:
17976672
15.

Male reproductive system parameters in a two-generation reproduction study of ammonium perfluorooctanoate in rats and human relevance.

York RG, Kennedy GL Jr, Olsen GW, Butenhoff JL.

Toxicology. 2010 Apr 30;271(1-2):64-72. doi: 10.1016/j.tox.2010.03.005. Epub 2010 Mar 17.

PMID:
20223269
16.

Perfluorooctanoic acid, perfluorooctanesulfonate, and serum lipids in children and adolescents: results from the C8 Health Project.

Frisbee SJ, Shankar A, Knox SS, Steenland K, Savitz DA, Fletcher T, Ducatman AM.

Arch Pediatr Adolesc Med. 2010 Sep;164(9):860-9. doi: 10.1001/archpediatrics.2010.163.

17.

Ammonium perfluorooctanoate production and occupational mortality.

Lundin JI, Alexander BH, Olsen GW, Church TR.

Epidemiology. 2009 Nov;20(6):921-8. doi: 10.1097/EDE.0b013e3181b5f395.

PMID:
19797969
18.

13-week dietary toxicity study of ammonium perfluorooctanoate (APFO) in male rats.

Perkins RG, Butenhoff JL, Kennedy GL Jr, Palazzolo MJ.

Drug Chem Toxicol. 2004 Nov;27(4):361-78.

PMID:
15573472
19.

Association of perfluorooctanoic acid with HDL cholesterol and circulating miR-26b and miR-199-3p in workers of a fluorochemical plant and nearby residents.

Wang J, Zhang Y, Zhang W, Jin Y, Dai J.

Environ Sci Technol. 2012 Sep 4;46(17):9274-81. doi: 10.1021/es300906q. Epub 2012 Aug 21.

PMID:
22862179
20.

Tracking the pathways of human exposure to perfluorocarboxylates.

Vestergren R, Cousins IT.

Environ Sci Technol. 2009 Aug 1;43(15):5565-75. Review.

PMID:
19731646

Supplemental Content

Support Center